Optimising Drug Delivery Research in Ireland

The Irish Drug Delivery Network has received a major investment of €5.2 million from Science Foundation Ireland as a strategic research cluster. €2.2 million further funding from industry means the research has an overall investment of €7.4 million direct costs over the coming five years. The IDDN is a network of scientists led by David Brayden, Professor of Drug Delivery at UCD, advancing research efforts to replace injections with oral and inhaled versions of biotech molecules (e.g. proteins and gene-based medicines).

Professor Brayden leads a team of scientists across four academic centres: the UCD Conway Institute, and the Schools of Pharmacy in Trinity College Dublin, Royal College of Surgeons in Ireland, and University College Cork.  Together, the scientists have a critical mass of expertise which, they hope, will create new and better methods of delivering biopharmaceuticals.